Daniel Abdun-Nabi, President & CEO at Emergent BioSolutions Inc. (EBS), sold 21,906 shares at $47.91 ($1.0M) on 2018-01-02, disclosed to the SEC on 2018-01-04.
Scheduled sale ($1.0M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EBS | SELL | 2018-09-18 | $1.9M | — | Filing → |
| EBS | SELL | 2018-09-06 | $5.5M | — | Filing → |
| EBS | SELL | 2018-06-07 | $823K | — | Filing → |